Hopefully the LANI phase III trial shows an improved performance compared to Tamiflu... now wouldn't that make headlines! Gee, you would think marketing partners would be jumping over each other to get their hands on LANI.
- Forums
- ASX - By Stock
- BTA
- h1n1: peramivir only 3x less useless tha tami
h1n1: peramivir only 3x less useless tha tami, page-3
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)